MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al Sotatercept for Pulmonary Arterial Hypertension within the First Year after
Diagnosis.
N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170. PubMedAbstract available
SIEDNER MJ, Magula N, Mazibuko L, Sithole N, et al Home-Based Care for Hypertension in Rural South Africa.
N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2509958. PubMedAbstract available
August 2025
FLACK JM, Azizi M, Brown JM, Dwyer JP, et al Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2507109. PubMedAbstract available
GUZIK TJ, Tomaszewski M Aldosterone Synthase Inhibition for Hypertension.
N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMe2511533. PubMed
BENETOS A, Gautier S, Freminet A, Metz A, et al Reduction of Antihypertensive Treatment in Nursing Home Residents.
N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2508157. PubMedAbstract available
LAFFIN LJ, Rodman D, Nissen SE Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.
N Engl J Med. 2025;393:726-727. PubMed
POLLOCK JM 3RD Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
N Engl J Med. 2025;393:726. PubMed
BURGOS E, Fernandez Fernandez B, Ortiz A Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
N Engl J Med. 2025;393:725-726. PubMed
June 2025
GARVEY WT, Bluher M, Osorto Contreras CK, Davies MJ, et al Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
N Engl J Med. 2025 Jun 22. doi: 10.1056/NEJMoa2502081. PubMedAbstract available
May 2025
MARON BA Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension.
N Engl J Med. 2025;392:2059-2061. PubMed
April 2025
LAFFIN LJ, Kopjar B, Melgaard C, Wolski K, et al Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
N Engl J Med. 2025 Apr 23. doi: 10.1056/NEJMoa2501440. PubMedAbstract available
March 2025
HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for
Death.
N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160. PubMedAbstract available
MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879. PubMedAbstract available
January 2025
VAIDYA A, Morlote M, Moussa M, Barletta J, et al Targeting a Hormonal Cause of Hypertension.
N Engl J Med. 2025;392:e14. PubMed
November 2024
BI Y, Li M, Liu Y, Li T, et al Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412006. PubMedAbstract available
June 2024
MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
N Engl J Med. 2024;390:2227. PubMed
May 2024
NAJEM M, Dong E Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
N Engl J Med. 2024;390:e47. PubMed
LI G, Lin Y, Yang J, Anderson CS, et al Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.
N Engl J Med. 2024 May 16. doi: 10.1056/NEJMoa2314741. PubMedAbstract available
EDLOW JA Lowering Blood Pressure in Stroke Patients in the Ambulance - A Bridge Too Close?
N Engl J Med. 2024 May 16. doi: 10.1056/NEJMe2402356. PubMed
April 2024
KUROLAP A, Chai Gadot C, Baris Feldman H Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
Reply.
N Engl J Med. 2024;390:1539-1540. PubMed
ABASSI Z, Azzam ZS, Heyman SN Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
N Engl J Med. 2024;390:1539. PubMed
GLADYSHEVA IP, Wang D, Reed GL Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
N Engl J Med. 2024;390:1538-1539. PubMed
DOMINY J, Koch C, Lamarche L, Denning D, et al Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
N Engl J Med. 2024;390:1537-1538. PubMed
CHEN B, Wei M Aortic Coarctation.
N Engl J Med. 2024;390:1420. PubMed
VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
N Engl J Med. 2024;390:1196-1206. PubMedAbstract available
December 2023
JAUREGUI R, Busis NA Idiopathic Intracranial Hypertension.
N Engl J Med. 2023;389:2467. PubMed
November 2023
BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
N Engl J Med. 2023;389:1685-1692. PubMedAbstract available
October 2023
DESAI AS, Sweetser MT, Bakris GL Zilebesiran for Hypertension. Reply.
N Engl J Med. 2023;389:1439-1440. PubMed
VAN TWIST DJL, Kalic H Zilebesiran for Hypertension.
N Engl J Med. 2023;389:1438-1439. PubMed
LIFSCHITZ M Zilebesiran for Hypertension.
N Engl J Med. 2023;389:1438. PubMed
ABASHEVA D, Fernandez-Fernandez B, Ortiz A Zilebesiran for Hypertension.
N Engl J Med. 2023;389:1438. PubMed